Certificate as per Regulation 3(5) and 3(6) of SEBI(PIT) Regulations,2015, for the quarter ended 30.06.2025.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has filed a routine compliance certificate under SEBI's Prohibition of Insider Trading (PIT) Regulations, 2015 for the quarter ended 30 June 2025. The Compliance Officer, Abdul Basith, certified that the company maintains a Structured Digital Database (SDD) to log Unpublished Price Sensitive Information (UPSI), with proper access controls, audit trails, and non-tamperable records retained for 8 years. The company recorded 1 UPSI event during the quarter and reported no non-compliance or violations from the previous quarter.
This is a standard regulatory compliance filing with no material impact on the stock or shareholders. It simply confirms the company is following SEBI's insider trading rules and has no reported lapses in handling sensitive information during the quarter.